Alhmoud Eman N, Abd El Samad Osama Badry, Elewa Hazem, Alkhozondar Ola, Soaly Ezeldin, El Anany Rasha
Al Wakra Hospital Hamad Medical Corporation Doha Qatar.
College of Pharmacy, QU Health Qatar University Doha- Qatar.
J Am Coll Clin Pharm. 2021 Sep;4(9):1117-1125. doi: 10.1002/jac5.1469. Epub 2021 May 20.
Coronavirus disease 2019 (COVID-19) pandemic has resulted in unprecedented pressure on healthcare systems and led to widespread utilization of telemedicine or telehealth services. Combined with teleclinics, using drive-up fingerstick International normalized ratio (INR) testing was recommended to decrease exposure risk of anticoagulation patients.
To evaluate the impact of transitioning from clinic-based anticoagulation management services to drive-up and phone-based services during COVID-19 pandemic in Qatar.
The study comprised of two components: a retrospective cohort study of all eligible patients who attended anticoagulation clinic over 1-year period (6 months before and 6 months after service transition) and a cross-sectional survey of eligible patients who agreed to provide data about their satisfaction with the new service. Monitoring parameters, clinical outcomes, and resource utilization related to warfarin therapy were compared before and after service transition. Patients' experience was explored through a structured survey.
There was no statistically significant difference between clinic-based and phone-based anticoagulation services in mean time and number of visits within therapeutic range ( = .67; = .06 respectively); mean number of extreme subtherapeutic and supratherapeutic INR values ( = .32 and = .34, respectively); incidence of thromboembolic complications and warfarin related hospitalization. There was one reported bleeding and one emergency visit (0.9%) in the phone-based group vs none in the clinic-based group. Frequency of INR testing and compliance to attending clinics appointments declined significantly ( = .002; = .001, respectively). Overall, patients were highly satisfied with the new service. The majority of patients found it better (51.6%) or just as good as the traditional service (44.5%). Patients who preferred the new service were significantly younger than their counterparts ( = .005).
The service of drive-up INR testing and phone-based consultations was shown to be comparable to traditional anticoagulation service, a finding that supports maintaining such services as part of the new normal after the pandemic is over.
2019年冠状病毒病(COVID-19)大流行给医疗系统带来了前所未有的压力,并导致远程医疗或远程健康服务的广泛使用。建议结合远程诊所,采用免下车指尖国际标准化比值(INR)检测,以降低抗凝患者的暴露风险。
评估卡塔尔在COVID-19大流行期间从基于诊所的抗凝管理服务过渡到免下车和基于电话的服务的影响。
该研究包括两个部分:一项对在1年期间(服务过渡前6个月和后6个月)到抗凝诊所就诊的所有符合条件患者的回顾性队列研究,以及一项对同意提供有关其对新服务满意度数据的符合条件患者的横断面调查。比较服务过渡前后与华法林治疗相关的监测参数、临床结局和资源利用情况。通过结构化调查探索患者的体验。
基于诊所的抗凝服务和基于电话的抗凝服务在治疗范围内的平均时间和就诊次数(分别为P=0.67;P=0.06);极端低于治疗范围和高于治疗范围的INR值的平均数量(分别为P=0.32和P=0.34);血栓栓塞并发症的发生率和与华法林相关的住院率方面,无统计学显著差异。基于电话的组报告有1例出血和1次急诊就诊(0.9%),而基于诊所的组无此类情况。INR检测频率和遵守诊所预约的情况显著下降(分别为P=0.002;P=0.001)。总体而言,患者对新服务高度满意。大多数患者认为新服务更好(51.6%)或与传统服务一样好(44.5%)。更喜欢新服务的患者明显比其同龄人年轻(P=0.005)。
免下车INR检测和基于电话的咨询服务被证明与传统抗凝服务相当,这一发现支持在大流行结束后将此类服务作为新常态的一部分予以维持。